BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance

British Journal of Dermatology

Volumn 161, Issue 2, 2009, Pages 364-372

  Da Forno, P D ^a   Pringle, J H ^b   Fletcher, A ^a   Bamford, M ^a   Su, L ^c   Potter, L ^b   Saldanha, G ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cancer progression; Melanoma; Mutation; Spitz naevus

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; HRAS PROTEIN, HUMAN; PROTEIN P21;

ADULT; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MELANOMA; MUTATION; NEVUS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN TUMOR;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MUTATION; NEVUS, EPITHELIOID AND SPINDLE CELL; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); SKIN NEOPLASMS;

EID: 73349116574     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09181.x     Document Type: Article

References (28)

1. Spitz S. Melanomas of childhood. Am J Pathol 1948; 24:591-609.
2. Cerroni L, Kerl H. Tutorial on melanocytic lesions. Am J Dermatopathol 2001; 23:237-41.
3. Barnhill RL, Argenyi ZB, From L et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30:513-20.
4. Mones JM, Ackerman AB. 'Atypical' Spitz's nevus, 'malignant' Spitz's nevus, and 'metastasizing' Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 2004; 26:310-33.
5. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod Pathol 2006; 19 (Suppl. 2):S21-33.
6. Urso C. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic. Am J Dermatopathol 2007; 29:491-4.
7. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135-47.
8. Gill M, Renwick N, Silvers DN et al. Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 2004; 122:1325-6.
9. Lee DA, Cohen JA, Twaddell WS et al. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer 2006; 106:907-13.
10. La Porta CA, Cardano R, Facchetti F et al. BRAF V599E mutation occurs in Spitz and Reed naevi. J Eur Acad Dermatol Venereol 2006; 20:1164-5.
11. Fullen DR, Poynter JN, Lowe L et al. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol 2006; 19:1324-32.
12. van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 2005; 29:1145-51.
13. Da Forno PD, Fletcher A, Pringle JH et al. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol 2008; 158:4-14.
14. Bastian BC, Olshen AB, LeBoit PE et al. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163:1765-70.
15. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157:967-72.
16. Takata M, Lin J, Takayanagi S et al. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br J Dermatol 2007; 156:1287-94.
17. Paniago-Pereira C, Maize JC, Ackerman AB. Nevus of large spindle and/or epithelioid cells (Spitz's nevus). Arch Dermatol 1978; 114:1811-23.
18. Saldanha G, Purnell D, Fletcher A et al. High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer 2004; 111:705-10.
19. Garrett KA. Use of statistical test of equivalence (bioequivalence tests) in plant pathology. Phytopathology 1997; 87:372-4.
20. Mones JM, Ackerman AB. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol 2003; 25:223-38.
21. Pol-Rodriquez M, Lee S, Silvers DN et al. Influence of age on survival in childhood spitzoid melanomas. Cancer 2007; 109:1579-83.
22. Barnhill RL. Childhood melanoma. Semin Diagn Pathol 1998; 15:189-94.
23. Barnhill RL. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston: Butterworth-Heinemann, 1995.
24. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24:4340-6.
25. Michaloglou C, Vredeveld LCW, Soengas MS et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-4.
26. Maldonado JL, Timmerman L, Fridlyand J et al. Mechanisms of cellcycle arrest in Spitz nevi with constitutive activation of the MAPkinase pathway. Am J Pathol 2004; 164:1783-7.
27. Denoyelle C, Abou-Rjaily G, Bezrookove V et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006; 8:1053-63.
28. Troxel DB. Medicolegal aspects of error in pathology. Arch Pathol Lab Med 2006; 130:617-19.